Status:
COMPLETED
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Lead Sponsor:
Amgen
Conditions:
Idiopathic Thrombocytopenic Purpura
Thrombocytopenia
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center prospective observational descriptive study complemented by a retrospective chart review. Patients diagnosed with ITP and currently treated for ITP by a hematologist or hematolo...
Detailed Description
Time Perspective: 12 months prospective chart review study with a retrospective chart review for a period up to 36 months from the start of the study, since the date of diagnosis for ITP.
Eligibility Criteria
Inclusion
- Has a diagnosis of ITP according to the American Society of Hematology guidelines (George et al., 1996).
- Is equal to or greater than 18 years of age.
- Is willing and able to complete a series of questionnaires.
- Before any study-specific procedure, the appropriate written informed consent must be obtained.
Exclusion
- Participated in clinical trial(s) during the past 36 months.
- Is considering participation in a clinical trial within the next 12 months.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT00454857
Start Date
May 1 2006
End Date
August 1 2008
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.